marijuana stocks news

Inergetics, Inc. (NRTI)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 558   430   524   480  
Cost of Revenue 438 360 310 363
Gross Profit 120   70   213   117  
Operating Expenses
Research Development 0 11 9 4
Selling General and Administrative 1,430 1,294 1,556 3,141
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (1,310) (1,235) (1,351) (3,028)
Income from Continuing Operations
Total Other Income/Expenses Net 3,245 (3,190) 509 (1,132)
Earnings Before Interest And Taxes 1,935 (4,425) (842) (4,160)
Interest Expense 241 (8) 401 367
Income Before Tax 1,694 (4,417) (1,243) (4,527)
Income Tax Expense (376) 2
Minority Interest
Net Income From Continuing Ops 1,875 (4,418) (1,240) (4,511)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income 2,070   (4,418) (1,243) (4,527)
Preferred Stock And Other Adjustments (332) (459) (322) (258)
Net Income Applicable To Common Shares 1,738   (4,878) (1,564) (4,785)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Biome Grow Inc. (BIO) (BIO.CN) Shows Continued Revenue Growth in Q3 2019

Biome Grow Shows Continued Revenue Growth in Q3 2019   Biome Grow…

Aurora Cannabis Inc. (ACBFF) Obtains Receipt of Australis Capital Final Prospectus

Aurora Cannabis Obtains Receipt of Australis Capital Final Prospectus and Provides Update…

INSYS Therapeutics, Inc. (INSY) Announces Participation at FDA Advisory Committee Meeting

INSYS Therapeutics Announces Participation at FDA Advisory Committee Meeting Addressing the Co-Prescribing…

Lexaria Bioscience Corp. (LXRP) Awarded Australian Patent For Cannabinoid Infused Edibles

Lexaria Bioscience Awarded Australian Patent For Cannabinoid Infused Edibles Lexaria Bioscience Corp. (LXRP)(CSE:LXX) (the…